The U.S. Food and Drug Administration on Thursday proposed excluding active ingredients for Novo Nordisk and Eli Lilly’s weight-loss drugs on the list of drugs outsourcing facilities can use for compounding. If finalized, the exclusion would limit compounding of these…[#item_full_content]
Top Gulf official offers glimmer of hope on Trump-Iran nuclear talks as threat of war hangs over region
Novembre 8, 2026
DUBAI, United Arab Emirates — A senior United Arab Emirates official says he is cautiously optimistic about negotiations between the United States and Iran, citing
